DrugDashboards

Prochlorperazine Edisylate

Prochlorperazine Edisylate · PROCHLORPERAZINE EDISYLATE 5 mg/mL · Injection · Intramuscular; Intravenous · HF Acquisition Co LLC, DBA HealthFirst

NDC 51662-1558-03 · 25 POUCH in 1 CASE / 1 VIAL in 1 POUCH / 2 mL in 1 VIAL · ANDA · View full market →

The short version

15 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Medicare Part B pays (ASP+6%)$2.76per billing unit (10 MG)HCPCS J0780 · Jul 1, 2026
  • Part D plans paid (avg)$2.66per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Medicare Part B (ASP)

Payment limit per 10 MG
$2.762
HCPCS J0780 · Jul 1, 2026 quarter · typically ASP + 6%

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $90.46 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA089903
TE code
AP
Approval date
Aug 29, 1989
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Prochlorperazine Edisylate (Injection)

LabelerStrengthFirst seenLast seen
Gland Pharma LimitedPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 3, 2026
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.PROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 3, 2026
Amneal Pharmaceuticals LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Caplin Steriles LimitedPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.PROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Cosette Pharmaceuticals, Inc.PROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Fosun Pharma Usa IncPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.PROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026
Somerset Therapeutics, LLCPROCHLORPERAZINE EDISYLATE 5 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Prochlorperazine Edisylate — NDC 51662-1558-03," retrieved September 3, 2026, https://drugdashboards.com/drug/51662155803.

Free to cite with attribution — see how the data is put together.